Cargando…

Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review

Hydralazine, an arterial vasodilator, is a widely used medication for the management of hypertension and heart failure, especially for patients who cannot tolerate the use of ACEIs or ARBs. It is generally well-tolerated and has a safe profile in pregnancy. However, hydralazine can induce immune-med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doughem, Karim, Battisha, Ayman, Sheikh, Omar, Konduru, Lakshmi, Madoukh, Bader, Al-Sadawi, Mohammed, Shaikh, Shakil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226194/ https://www.ncbi.nlm.nih.gov/pubmed/32418528 http://dx.doi.org/10.2174/1573403X16666200518092814

Ejemplares similares

Acute Myocardial Infarction in Systemic Mastocytosis: Case Report With Literature Review on the Role of Inflammatory Process in Acute Coronary Syndrome
por: Battisha, Ayman, et al.
Publicado: (2020)

Coronary Fistula Between Left Anterior Descending Artery (LAD) and Pulmonary Artery (PA) Leading to Sudden Cardiac Death: Case Report with Literature Review
por: Battisha, Ayman, et al.
Publicado: (2020)

Spontaneous Biliary Pericardial Tamponade: A Case Report and Literature Review
por: Battisha, Ayman, et al.
Publicado: (2021)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
por: Khosla, Atulya Aman, et al.
Publicado: (2023)

A rare presentation of Austrian syndrome with septic arthritis in an immunocompetent female
por: Battisha, Ayman, et al.
Publicado: (2019)

Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
por: Zuckerman, Roman, et al.
Publicado: (2018)

Hydralazine-Induced Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
por: Echevarria, Victoria, et al.
Publicado: (2023)

State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure
por: Al-Sadawi, Mohammed, et al.
Publicado: (2021)

Hydralazine-Induced Vasculitis
por: Gandhi, Pulkit, et al.
Publicado: (2023)

Iatrogenic Right Atrial Thrombus Complicated by Pulmonary Embolism: Management and Outcomes
por: Battisha, Ayman, et al.
Publicado: (2021)

Hydralazine-Induced Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Case Report and Literature Review
por: Alawneh, Diala, et al.
Publicado: (2022)

Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist
por: Lee, Jennifer J. Y., et al.
Publicado: (2019)

Different Types of ANCA Determine Different Clinical Phenotypes and Outcome in ANCA-Associated Vasculitis (AAV)
por: Bantis, Kostas, et al.
Publicado: (2022)

Hydralazine-Induced Vasculitis With Gastrointestinal Pseudomelanosis
por: Novikov, Aleksey, et al.
Publicado: (2014)

Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
por: Strubchevska, Kateryna, et al.
Publicado: (2023)

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndrome
por: Aeddula, Narothama Reddy, et al.
Publicado: (2018)

Overlapping Syndromes: Drug-Induced Vasculitis From Hydralazine With Positive Antinuclear Antibodies
por: Kannan, Lakshmi, et al.
Publicado: (2023)

Hydralazine-induced vasculitis presenting with ocular manifestations
por: Hawn, Vivian S., et al.
Publicado: (2022)

Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation
por: Tu, Wan, et al.
Publicado: (2021)

Rare complication of a commonly used antihypertensive agent: A case of hydralazine‐induced ANCA‐associated vasculitis presenting as rapidly progressive glomerulonephritis
por: Warren, Kayle, et al.
Publicado: (2022)

Diffuse hydralazine-associated vasculitis with pathergy: An overlapping picture of Sweet syndrome and bullous vasculitis
por: Banbury, Sara, et al.
Publicado: (2023)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) Masquerading As Mononeuritis Multiplex: A Case Report
por: Patel, Anandkumar, et al.
Publicado: (2023)

Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary–renal syndrome: a case report
por: Al-Abdouh, Ahmad, et al.
Publicado: (2020)

Hydralazine-Induced Dual Antineutrophil Cytoplasmic Antibody Positive Vasculitis and Nephritis
por: Padala, Sandeep A, et al.
Publicado: (2020)

Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity
por: Herrmann, K, et al.
Publicado: (2015)

Predictors of poor prognosis in ANCA-associated vasculitis (AAV): a single-center prospective study of inpatients in China
por: Gao, Ronglin, et al.
Publicado: (2022)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

PRS
por: Sphicas, Paris
Publicado: (2004)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report
por: Li, Xiao-li, et al.
Publicado: (2017)

Hydralazine Induces Myeloperoxidase and Proteinase 3 Anti-Neutrophil Cytoplasmic Antibody Vasculitis and Leads to Pulmonary Renal Syndrome
por: Agarwal, Gaurav, et al.
Publicado: (2014)

A hydralazine-induced triumvirate: Lupus, cutaneous vasculitis, and cryptococcoid Sweet syndrome
por: Skaljic, Meliha, et al.
Publicado: (2019)

Focal Alveolar Hemorrhage Secondary to Hydralazine-Associated Antineutrophilic Cytoplasmic Antibody Vasculitis
por: Martinez Manzano, Jose M, et al.
Publicado: (2023)

Challenges of defining renal response in ANCA-associated vasculitis: call to action?
por: Odler, Balazs, et al.
Publicado: (2023)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3153pthqdeaeuqigjgunl57iva